(Featuring Max Shepherd, Director of Global Real Assets, Sheffield Haworth, London, and Jannah Babasa, Senior Associate, Global Real Assets, Sheffield Haworth, New York)
As the global life sciences sector continues to grow in real estate, highly specialized skills and experience will be the keys to success.
https://www.afire.org/podcast/lifesciencescast/
In a year of poor performance in some commercial real estate sectors, investors and developers are eyeing up a move into life sciences, but do the risks outweigh the potential benefits?
The life sciences industry consists of companies operating in pharmaceuticals, biotechnology, medical devices, biomedical technologies, nutraceuticals, cosmeceuticals, and food processing. Recent growth, partially driven by the pandemic, has centered on the health and medical side of the industry, including businesses dedicated to developing, producing, and commercializing innovative treatments, diagnostic tools, equipment, and software to improve and prolong lives.
On this episode of the AFIRE Podcast, Max Shepherd and Jannah Babasa of Sheffield Haworth examine how the pandemic highlighted the resilience of life sciences compared with other commercial real estate sectors. This has led to changes in government policy and increases in public and private funding for the sector.